0.0250
+0.0050
+(25.00%)
At close: January 10 at 11:23:36 AM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Sameet Kanade CPA, MBA | CEO & Director | 287.5k | -- | -- |
| Ms. Patricia Militello | Interim Chief Financial Officer | 54.5k | -- | -- |
| Mr. Robert Tjandra B.Sc., M.B.A. | Founder | 114k | -- | -- |
| Mr. Adrian Burke | Vice President of Marketing | -- | -- | -- |
Steep Hill Inc.
30 Commercial Road
East York
Toronto, ON M4G 1Z4
Canada
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Steep Hill Inc. does not have significant operations. Previously, it operated as a cannabis-science company in Canada. The company was formerly known as Cannabis Clonal Corporation and changed its name to Steep Hill Inc. in February 2022. The company was founded in 2008 and is based in Toronto, Canada.
Corporate Governance
Steep Hill Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 1, 2024 at 8:00 PM UTC
Steep Hill Inc. Earnings Date
Recent Events
Recent Events Information Not Available